Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)

Market Cap	12.42B -4.0%
Revenue (ttm)	3.96B +9.6%
Net Income	789.02M +5.3%
EPS	1.39 +4.7%
Shares Out	563.16M
PE Ratio	15.86
Forward PE	14.80
Dividend	0.90 (4.11%)
Ex-Dividend Date	Jun 20, 2025

Volume	2,725,889
Average Volume	8,450,213
Open	22.08
Previous Close	22.05
Day's Range	21.75 - 22.17
52-Week Range	20.30 - 24.94
Beta	0.13
RSI	47.85
Earnings Date	Apr 28, 2026

About SHA:600285

Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering approximately 100 product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is based in Xinyang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 2,435
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600285

Financial Performance

In 2025, SHA:600285's revenue was 3.85 billion, an increase of 10.07% compared to the previous year's 3.50 billion. Earnings were 759.50 million, an increase of 5.11%.